Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Molina Healthcare Inc. Revenue & Financial Statements
Molina Healthcare Inc. reported revenue of $45.4B for the fiscal year ended December 31, 2025, up 11.7% year over year, with net income of $472.0M and diluted EPS of $8.92.
- Company
- Molina Healthcare Inc. MOH · NYSE
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 77.0M | 75.0M | 34.1B | 40.6B | 45.4B |
| Cost of revenue | 23.7B | 27.2B | 28.7B | 34.4B | 39.5B |
| Gross profit | (23.6B) | (27.1B) | 5.4B | 6.2B | 5.9B |
| Operating income | 1.0B | 1.2B | 1.6B | 1.7B | 781.0M |
| Pretax income | 875.0M | 1.1B | 1.5B | 1.6B | 0 |
| Net income | 659.0M | 792.0M | 1.1B | 1.2B | 472.0M |
| Diluted EPS | 11.25 | 13.55 | 18.77 | 20.42 | 8.92 |
| EBITDA | 1.0B | 1.2B | 1.6B | 1.7B | 976.0M |
Quarterly
| USD | Q4 '24 | Q2 '25 | Q1 '25 | Q3 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.5B | — | 11.1B | — | 11.4B | 11.5B | 11.4B | 10.8B |
| Cost of revenue | 9.0B | — | 9.5B | — | 9.8B | 10.0B | 10.1B | 9.3B |
| Gross profit | 1.5B | — | 1.7B | — | 1.6B | 1.4B | 1.2B | 1.5B |
| Operating income | 380.0M | — | 433.0M | — | 373.0M | 137.0M | (162.0M) | 83.0M |
| Pretax income | 346.0M | — | 390.0M | — | 325.0M | 88.0M | (214.0M) | 29.0M |
| Net income | 251.0M | 298.0M | 298.0M | 255.0M | 255.0M | 79.0M | (160.0M) | 14.0M |
| Diluted EPS | 4.45 | — | 5.45 | — | 4.75 | 1.51 | -2.87 | 0.27 |
| EBITDA | 428.0M | — | 481.0M | — | 431.0M | 182.0M | (118.0M) | 122.0M |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 12.2B | 12.3B | 14.9B | 15.6B | 15.6B |
| Current assets | 10.1B | 10.1B | 12.5B | 12.8B | 12.4B |
| Cash & equivalents | 4.4B | 4.0B | 4.8B | 4.7B | 4.2B |
| Total liabilities | 9.6B | 9.3B | 10.7B | 11.1B | 11.5B |
| Current liabilities | 7.0B | 6.9B | 8.2B | 7.9B | 7.4B |
| Long-term debt | 2.2B | 2.2B | 2.2B | 2.9B | 3.8B |
| Total debt | 2.2B | 2.2B | 2.2B | 2.9B | 3.8B |
| Stockholders’ equity | 2.6B | 3.0B | 4.2B | 4.5B | 4.1B |
| Net debt | (2.3B) | (1.8B) | (2.7B) | (1.7B) | (482.0M) |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 2.1B | 773.0M | 1.7B | 644.0M | (535.0M) |
| Investing cash flow | (1.7B) | (790.0M) | (744.0M) | (464.0M) | 312.0M |
| Financing cash flow | (183.0M) | (441.0M) | (58.0M) | (347.0M) | (170.0M) |
| Capital expenditure | 77.0M | 91.0M | 84.0M | 100.0M | 101.0M |
| Free cash flow | 2.0B | 682.0M | 1.6B | 544.0M | (636.0M) |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 72.0M | 103.0M | 115.0M | 116.0M | 47.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every MOH filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.